Hegde Priti 4
4 · TCR2 THERAPEUTICS INC. · Filed Dec 10, 2021
Insider Transaction Report
Form 4
Hegde Priti
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-12-09+12,100→ 12,100 totalExercise: $5.21Exp: 2031-12-08→ Common Stock (12,100 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on January 1, 2023, with the remainder vesting in twenty-four (24) equal monthly installments thereafter.